Search

Bernadette M Cusack

from Jacksonville Beach, FL
Age ~77
Get Report
Also known as:
Bernade Cusack, Bernadett Cusack, Kevin Cusack
Phone and address:
1773 Evans Dr S, Jacksonville, FL 32250
(904) 246-1966
Related to:
Maurice G Cusack, 77Allison M Wikoff, 43Nicolas Wikoff, 41Gregory P Cusack, 40Laura K Ruiz, 42Kevin A Cusack, 38
Connected to:
Amy Cusack, 52Bradly Cusack, 39Brian J Cusack, 45Cameron A Cusack, 39Charlene K Cusack, 60Charles C Cusack, 60Christopher A Cusack, 54Cory A Cusack, 47Craig A Cusack, 70Erin Cusack, 42

Bernadette Cusack Phones & Addresses

  • 1773 Evans Dr S, Jacksonville Beach, FL 32250 (904) 246-1966
  • 1773 Evans Rd, Jax Bch, FL 32250 (904) 246-1966
  • Jacksonville, FL
  • South Hamilton, MA
  • Ponte Vedra Beach, FL

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Professional Records

License Records

Bernadette J Cusack

Phone:
(705) 687-5760
License #:
9237291 - Expired
Category:
Health Care
Issued Date:
Feb 9, 2006
Effective Date:
May 15, 2017
Expiration Date:
Apr 30, 2017
Type:
Registered Nurse

Resumes

Resumes

Bernadette Cusack Photo 1

Technology Development Liaison, Mayo Clinic Ventures

View page
Location:
4500 San Pablo Rd south, Jacksonville, FL 32224
Industry:
Hospital & Health Care
Work:
Mayo Clinic 1989 - 2008
Associate In Research, Neuroscience
Mayo Clinic 1989 - 2008
Technology Development Liaison, Mayo Clinic Ventures
Massachusetts Institute of Technology (Mit) 1976 - 1980
Academic Staff and Laboratory Supervisor, Laboratory of Neuroendocrine Regulation
Massachusetts Institute of Technology (Mit) 1972 - 1976
Academic Staff and Laboratory Supervisor, Arteriosclerosis Center, Scor Center
Harvard Medical School 1970 - 1972
Joslin Diabetes Center, Laboratory Assistant
Education:
Emmanuel College
Bachelors, Bachelor of Arts, Biology The Johns Hopkins University
Master of Arts In Teaching, Masters, Biology
Skills:
Neuroscience
Data Analysis
Clinical Research
Biotechnology
Lifesciences
Healthcare
Cell Biology
Cell Culture
Medical Devices
Protein Purification
Business Development
Technology Transfer
Licensing Negotiations
Mentoring of Staff
Prior Art Search
Strategic Technology Development
Client Development
Bernadette Cusack Photo 2

Bernadette Cusack

View page
Location:
1773 Evans Dr south, Jacksonville Beach, FL 32250
Industry:
Hospital & Health Care
Work:
Mayo Clinic
Retired
Bernadette Cusack Photo 3

Bernadette Cusack

View page

Publications

Us Patents

Using Polyamide Nucleic Acid Oligomers To Engender A Biological Response

View page
US Patent:
6472209, Oct 29, 2002
Filed:
Oct 17, 1997
Appl. No.:
08/953269
Inventors:
Elliott Richelson - Ponte Vedra Beach FL
Beth Marie Tyler - Neptune Beach FL
Daniel J. McCormick - Rochester MN
Bernadette Marie Cusack - Jacksonville Beach FL
Clark V. Hoshall - Ponte Vedra Beach FL
Christopher Lee Douglas - Jacksonville FL
Karen Jansen - Jacksonville FL
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 2104
US Classification:
435375, 435 6, 435377, 514 44, 536 245, 536 241, 536 187
Abstract:
The invention involves methods and materials for extracellularly administering PNA oligomers to living cells. Specifically, the invention provides methods of treating living cells with PNA oligomers such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. This invention also provides methods of screening potential PNA oligomers for the ability to engender a sequence specific biological response. Further, this invention provides methods of identifying the function of polypeptides and of determining the relative turnover rate of functional polypeptides.

Using Polyamide Nucleic Acid Oligomers To Engender A Biological Response

View page
US Patent:
6723560, Apr 20, 2004
Filed:
Oct 8, 1998
Appl. No.:
09/168791
Inventors:
Elliott Richelson - Ponte Vedra Beach FL
Beth Marie Tyler - Neptune Beach FL
Bernadette Marie Cusack - Jacksonville FL
Christopher Lee Douglas - Jacksonville FL
Karen Jansen - Jacksonville FL
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 2104
US Classification:
435375, 435 6, 435325, 435377, 514 44, 536 187, 536 241, 536 245
Abstract:
The invention involves methods and materials for extracellularly administering PNA oligomers to living cells. Specifically, the invention provides methods and materials of treating living cells with PNA oligomers such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. In addition, the invention provides methods and materials for orally administering PNA oligomers to animals such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. The invention also provides sense and antisense PNA oligomers that modulate transcription and translation, respectively. The invention also provides mismatch PNA oligomers that modulate the degree of an engendered biological response. In addition, the invention provides methods and materials for detecting PNA oligomers within a biological sample collected from an animal. Further, the invention provides methods and materials for screening potential PNA oligomers for the ability to engender a sequence specific biological response.

Using Polyamide Nucleic Acid Oligomers To Engender A Biological Response

View page
US Patent:
6743627, Jun 1, 2004
Filed:
Jan 30, 1998
Appl. No.:
09/016685
Inventors:
Elliott Richelson - Ponte Vedra Beach FL
Beth Marie Tyler - Neptune Beach FL
Daniel J. McCormick - Rochester MN
Bernadette Marie Cusack - Jacksonville Beach FL
Clark V. Hoshall - Ponte Vedra Beach FL
Christopher Lee Douglas - Jacksonville FL
Karen Jansen - Jacksonville FL
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07K 2104
US Classification:
435375, 435 6, 435377, 536 187, 536 241, 536 245, 514 44
Abstract:
The invention involves methods and materials for extracellularly administering PNA oligomers to living cells. Specifically, the invention provides methods of treating living cells with PNA oligomers such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. In addition, the invention provides methods and materials for orally administering PNA oligomers to animals such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. This invention also provides methods of screening potential PNA oligomers for the ability to engender a sequence specific biological response. Further, this invention provides methods of identifying the function of polypeptides and of determining the relative turnover rate of functional polypeptides.

Neo-Tryptophan

View page
US Patent:
6765099, Jul 20, 2004
Filed:
Oct 4, 2002
Appl. No.:
10/265099
Inventors:
Elliott Richelson - Ponte Vedra Beach FL
Bernadette Marie Cusack - Jacksonville FL
Yuan-Ping Pang - Rochester MN
Daniel J. McCormick - Rochester MN
Abdul Fauq - Jacksonville FL
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07D20914
US Classification:
548503
Abstract:
The invention provides a novel amino acid, neo-tryptophan, as well as polypeptides containing this novel amino acid such as neurotensin analogs. In addition, the invention provides neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and polypeptides containing such derivatives. The invention also provides methods for making neo-tryptophan, neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and compositions containing these compounds. Further, the invention provides methods for inducing a neurotensin response in a mammal as well as methods for treating a mammal having a serotonin recognition molecule.

Neo-Tryptophan

View page
US Patent:
6921805, Jul 26, 2005
Filed:
Jun 1, 2004
Appl. No.:
10/858226
Inventors:
Elliott Richelson - Ponte Vedra Beach FL, US
Bernadette Marie Cusack - Jacksonville FL, US
Yuan-Ping Pang - Rochester MN, US
Daniel J. McCormick - Rochester MN, US
Abdul Fauq - Jacksonville FL, US
Beth Marie Tyler - Neptune Beach FL, US
Mona Boules - Jacksonville FL, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K038/08
C07K007/06
US Classification:
530329, 514 17
Abstract:
The invention provides a novel amino acid, neo-tryptophan, as well as polypeptides containing this novel amino acid such as neurotensin analogs. In addition, the invention provides neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and polypeptides containing such derivatives. The invention also provides methods for making neo-tryptophan, neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and compositions containing these compounds. Further, the invention provides methods for inducing a neurotensin response in a mammal as well as methods for treating a mammal having a serotonin recognition molecule.

Using Polyamide Nucleic Acid Oligomers To Engender A Biological Response

View page
US Patent:
6989270, Jan 24, 2006
Filed:
Oct 8, 1998
Appl. No.:
09/168714
Inventors:
Elliott Richelson - Ponte Vedra Beach FL, US
Beth Marie Tyler - Neptune Beach FL, US
Bernadette Marie Cusack - Jacksonville Beach FL, US
Christopher Lee Douglas - Jacksonville FL, US
Karen Jansen - Jacksonville FL, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07H 21/04
C12N 15/00
A61K 48/00
US Classification:
435375, 435 6, 435377, 435455, 514 44, 514 2, 536 187, 536 241, 536 245
Abstract:
The invention involves methods and materials for extracellularly administering PNA oligomers to living cells. Specifically, the invention provides methods and materials of treating living cells with PNA oligomers such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. In addition, the invention provides methods and materials for orally administering PNA oligomers to animals such that the oligomers cross biological barriers and engender a biological response in a sequence specific manner. The invention also provides sense and antisense PNA oligomers that modulate transcription and translation, respectively. The invention also provides mismatch PNA oligomers that modulate the degree of an engendered biological response. In addition, the invention provides methods and materials for detecting PNA oligomers within a biological sample collected from an animal. Further, the invention provides methods and materials for screening potential PNA oligomers for the ability to engender a sequence specific biological response.

Neo-Tryptophan

View page
US Patent:
7098307, Aug 29, 2006
Filed:
Jul 8, 2005
Appl. No.:
11/178269
Inventors:
Elliott Richelson - Ponte Vedra Beach FL, US
Bernadette Marie Cusack - Jacksonville FL, US
Yuan-Ping Pang - Rochester MN, US
Daniel J. McCormick - Rochester MN, US
Abdul Fauq - Jacksonville FL, US
Beth Marie Tyler - Neptune Beach FL, US
Mona Boules - Jacksonville FL, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
C07K 1/06
C07K 7/06
US Classification:
530329, 530333
Abstract:
The invention provides a novel amino acid, neo-tryptophan, as well as polypeptides containing this novel amino acid such as neurotensin analogs. In addition, the invention provides neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and polypeptides containing such derivatives. The invention also provides methods for making neo-tryptophan, neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and compositions containing these compounds. Further, the invention provides methods for inducing a neurotensin response in a mammal as well as methods for treating a mammal having a serotonin recognition molecule.

Neo-Tryptophan

View page
US Patent:
7642231, Jan 5, 2010
Filed:
Jun 14, 2006
Appl. No.:
11/452616
Inventors:
Elliott Richelson - Ponte Vedra Beach FL, US
Bernadette Marie Cusack - Jacksonville FL, US
Yuan-Ping Pang - Rochester MN, US
Daniel J. McCormick - Rochester MN, US
Abdul Fauq - Jacksonville FL, US
Beth Marie Tyler - Neptune Beach FL, US
Mona Boules - Jacksonville FL, US
Assignee:
Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:
A61K 38/02
A61K 38/08
US Classification:
514 2, 514 17
Abstract:
The invention provides a novel amino acid, neo-tryptophan, as well as polypeptides containing this novel amino acid such as neurotensin analogs. In addition, the invention provides neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and polypeptides containing such derivatives. The invention also provides methods for making neo-tryptophan, neo-tryptophan derivatives, serotonin-like neo-tryptophan derivatives, and compositions containing these compounds. Further, the invention provides methods for inducing a neurotensin response in a mammal as well as methods for treating a mammal having a serotonin recognition molecule.
Control profile
Bernadette M Cusack from Jacksonville Beach, FL, age ~77 Get Report